Chen M - Search Results

1

CRISPR-Cas9 for cancer therapy: Opportunities and challenges.

Chen M, Mao A, Xu M, Weng Q, Mao J, Ji J. Chen M, et al. Cancer Lett. 2019 Apr 10;447:48-55. doi: 10.1016/j.canlet.2019.01.017. Epub 2019 Jan 23. Cancer Lett. 2019. PMID: 30684591 Review.

2

SMAD7 loci contribute to risk of hepatocellular carcinoma and clinicopathologic development among Chinese Han population.

Ji J, Xu M, Zhao Z, Tu J, Gao J, Lu C, Song J, Chen W, Chen M, Fan X, Cheng X, Lan X, Li J. Ji J, et al. Among authors: chen m, chen w. Oncotarget. 2016 Apr 19;7(16):22186-92. doi: 10.18632/oncotarget.8065. Oncotarget. 2016. PMID: 26989026 Free PMC article.

3

Identification of key metabolic changes in renal interstitial fibrosis rats using metabonomics and pharmacology.

Zhao L, Dong M, Liao S, Du Y, Zhou Q, Zheng H, Chen M, Ji J, Gao H. Zhao L, et al. Among authors: chen m. Sci Rep. 2016 Jun 3;6:27194. doi: 10.1038/srep27194. Sci Rep. 2016. PMID: 27256510 Free PMC article.

4

High Glucose-Induced PC12 Cell Death by Increasing Glutamate Production and Decreasing Methyl Group Metabolism.

Chen M, Zheng H, Wei T, Wang D, Xia H, Zhao L, Ji J, Gao H. Chen M, et al. Biomed Res Int. 2016;2016:4125731. doi: 10.1155/2016/4125731. Epub 2016 Jun 19. Biomed Res Int. 2016. PMID: 27413747 Free PMC article.

5

Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps.

Zheng H, Ji J, Zhao L, Chen M, Shi A, Pan L, Huang Y, Zhang H, Dong B, Gao H. Zheng H, et al. Among authors: chen m. Oncotarget. 2016 Sep 13;7(37):59189-59198. doi: 10.18632/oncotarget.10830. Oncotarget. 2016. PMID: 27463020 Free PMC article.

6

Inhibition of microRNA-126 promotes the expression of Spred1 to inhibit angiogenesis in hepatocellular carcinoma after transcatheter arterial chemoembolization: in vivo study.

Ji JS, Xu M, Song JJ, Zhao ZW, Chen MJ, Chen WQ, Tu JF, Yang XM. Ji JS, et al. Among authors: chen mj, chen wq. Onco Targets Ther. 2016 Jul 19;9:4357-67. doi: 10.2147/OTT.S106513. eCollection 2016. Onco Targets Ther. 2016. PMID: 27499630 Free PMC article.

7

MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinoma.

Ji J, Xu M, Tu J, Zhao Z, Gao J, Chen M, Song J, Zhu H, Cheng X, Hui J, Lan X, Yang X. Ji J, et al. Among authors: chen m. Oncotarget. 2016 Sep 13;7(37):60303-60309. doi: 10.18632/oncotarget.11206. Oncotarget. 2016. PMID: 27531892 Free PMC article.

8

Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.

Song J, Zhao Z, Fan X, Chen M, Cheng X, Zhang D, Wu F, Ying X, Ji J. Song J, et al. Among authors: chen m. Oncotarget. 2016 Oct 25;7(43):70504-70515. doi: 10.18632/oncotarget.12041. Oncotarget. 2016. PMID: 27655700 Free PMC article.

9

Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer.

Xu M, Zhao Z, Song J, Lan X, Lu S, Chen M, Wang Z, Chen W, Fan X, Wu F, Chen L, Tu J, Ji J. Xu M, et al. Among authors: chen l, chen m, chen w. Exp Cell Res. 2017 Feb 15;351(2):142-149. doi: 10.1016/j.yexcr.2017.01.008. Epub 2017 Jan 19. Exp Cell Res. 2017. PMID: 28109867

10

¹²⁵I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy: a comparison with best supportive care.

Song J, Fan X, Zhao Z, Chen M, Chen W, Wu F, Zhang D, Chen L, Tu J, Ji J. Song J, et al. Among authors: chen l, chen m, chen w. Onco Targets Ther. 2017 Mar 2;10:1345-1352. doi: 10.2147/OTT.S129903. eCollection 2017. Onco Targets Ther. 2017. PMID: 28280369 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50,659 results

Search Page

Filters